| P2093 | author name string | Françoise Mornex | |
| | Nicolas Girard | |
| P2860 | cites work | Quality assurance in conformal radiotherapy: DYNARAD consensus report on practice guidelines | Q28258645 |
| | Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer | Q28278736 |
| | Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck | Q29619277 |
| | Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee | Q30584885 |
| | Treatment of non-small cell lung cancer with intensity-modulated radiation therapy in combination with cetuximab: the NEAR protocol (NCT00115518). | Q33242719 |
| | Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer | Q33344354 |
| | Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431. | Q33344687 |
| | The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer | Q33912268 |
| | Set-up verification using portal imaging; review of current clinical practice | Q34134885 |
| | Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer | Q34323659 |
| | Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art. | Q36503016 |
| | Influence of the positioning error on 3D conformal dose distributions during fractionated radiotherapy. | Q36718347 |
| | Stereotactic radiosurgery for thoracic malignancies | Q37067980 |
| | The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours | Q39512984 |
| | Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy | Q43746300 |
| | Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer | Q44263737 |
| | Effects of radiotherapy and chemotherapy on lung function in patients with non–small-cell lung cancer | Q44403167 |
| | Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504 | Q44438556 |
| | Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial. | Q44663688 |
| | Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients | Q44808451 |
| | Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study | Q45056439 |
| | Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium | Q45130078 |
| | Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial | Q45130082 |
| | Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. | Q46589628 |
| | Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 S | Q46641106 |
| | Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-sm | Q46720865 |
| | Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. | Q50690978 |
| | Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. | Q51013426 |
| | High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. | Q52032135 |
| | The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. | Q53229977 |
| | Potential benefits of using non coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes. | Q53522898 |
| | Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. | Q53772021 |
| | The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. | Q53840653 |
| | Final toxicity results of a radiation-dose escalation study in patients with non–small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis | Q57619430 |
| | Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated Radiotherapy | Q60543139 |
| | Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer | Q60685497 |
| | Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non–Small-Cell Lung Cancer: A Randomized Phase II Locally Advanced Multi-Modality Protocol | Q61889869 |
| | The use of active breathing control (ABC) to reduce margin for breathing motion | Q61903157 |
| | Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer | Q67485777 |
| | Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer | Q72082620 |
| | Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer | Q72134633 |
| | A feasibility study of extended chemotherapy for locally advanced non-small cell lung cancer: a phase II trial of cancer and leukemia group B | Q72428305 |
| | Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) | Q72992550 |
| | Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer | Q73181790 |
| | Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial | Q73336874 |
| | Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications | Q74176641 |
| | Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04 | Q74292789 |
| | Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing | Q77157429 |
| | Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973) | Q79329348 |
| | High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer | Q80972522 |
| | Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience | Q81021240 |
| | Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers | Q81211239 |
| | Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma | Q81312777 |
| | A brief report on the safety study of induction chemotherapy followed by synchronous radiotherapy and cetuximab in stage III non-small cell lung cancer (NSCLC): SCRATCH study | Q81388294 |
| | Cone-beam computed tomographic image guidance for lung cancer radiation therapy | Q83027599 |
| | Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer | Q84067997 |
| P304 | page(s) | 113-125 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | European Journal of Cancer | Q332260 |
| P1476 | title | Radiotherapy for locally advanced non-small cell lung cancer | |
| P478 | volume | 45 Suppl 1 | |